The pair of Phase 2b clinical trials run by the HIV Vaccine Trials Network (HVTN), which is headquartered at Fred Hutchinson Cancer Research Center, and the HIV Prevention Trials Network (HPTN) have enrolled 4,625 participants who are at risk for HIV infection from communities in the United States, Brazil, Peru, Switzerland, and sub-Saharan Africa.
Diteko tse pedi tsa ditekeletso tsa kalafi tsa Karolo 2b tse di tsamaisiwang ke HIV Vaccine Trials Network (HVTN) le HIV Prevention Trials Network (HPTN) di kwadisise batsayakarolo ba le 4,625 ba ba mo kotsing ya go tshwaediwa ke HIV mo mafelong a Amerika Bokone le Borwa, Yuropa, le Aforika e e mo Borwa jwa Sahara.